Real-World antibiotic study cut short: what we can learn
NCT ID NCT05487586
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tracked how the antibiotic ceftazidime-avibactam is used in real hospital settings in China for serious infections like pneumonia and abdominal infections. Researchers planned to enroll 450 patients but the study was terminated early. The goal was to see how often the drug clears the infection and how bacteria respond, providing insights for doctors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
ceftazidime-avibactam
What this could lead to
If successful, this study could provide real-world data on how well ceftazidime-avibactam works against tough hospital infections in everyday practice.
What could go wrong
This was an observational study that was terminated early, so results may be limited. It does not test a new treatment, only observes current use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HOSPITAL-ACQUIRED PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Tsinghua Changgung Hospital
Beijing, China
-
Henan Provincial People's Hospital
Zhengzhou, China
-
Huashan Hospital Fudan University
Shanghai, Shanghai Municipality, 200040, China
-
Shanghai Tenth People's Hospital
Shanghai, China
-
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
Hangzhou, China
-
The Affiliated People's Hospital of Ningbo University
Ningbo, China
-
The First Affiliated Hospital of Nanchang University
Nanchang, China
-
The First Affiliated Hospital of Soochow University
Suzhou, China
-
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
-
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, China
-
The First affiliated Hospital of Anhui Medical University
Hefei, China
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, China
-
The Second People's Hospital of Hebei Medical University
Shijiazhuang, China
-
The Third Hospital of Hebei Medical University
Shijiazhuang, China
-
Tianjin Medical University General Hospital
Tianjing, China
-
Xiangya Hospital Central South University
Changsha, China
-
Zhongda Hospital Southeast University
Nanjing, China